Literature DB >> 2205629

Secondary hypogonadism in older men: its relation to impotence.

S G Korenman1, J E Morley, A D Mooradian, S S Davis, F E Kaiser, A J Silver, S P Viosca, D Garza.   

Abstract

The relation of the reproductive endocrine system to impotence in older men was examined by measuring the concentrations of testosterone (T), bioavailable testosterone (BT), LH, and PRL and body mass index (BMI) in 57 young controls (YC), 50 healthy potent older controls attending a health fair (HF), and 267 impotent patients (SD). The SD and HF had markedly reduced mean T and BT values compared to YC. When adjusted for age and BMI there was no difference in BT between potent and impotent older men. The percent BT was much higher in YC than in the older groups. While the percent BT rose significantly with increased T in YC, it was inversely related to T in the older subjects, suggesting that increased sex hormone-binding globulin binding was a primary event leading to a low BT. Forty-eight percent of HF and 39% of SD were hypogonadal, as defined by a mean BT of 2.5 SD or more below the mean of YC (less than or equal to 2.3 nmol/L). Ninety percent of these had LH values in the normal range, suggesting hypothalamic-pituitary dysfunction. Thirty-four SD and six each of YC and older control volunteers (OC) underwent GnRH testing. Older subjects showed impaired responsiveness to GnRH compared to YC. A low basal LH level correlated very highly with hyporesponsiveness to GnRH. Thus, secondary hypogonadism and impotence are two common, independently distributed conditions of older men.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205629     DOI: 10.1210/jcem-71-4-963

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  For and against: The male menopause--does it exist?

Authors:  D C Gould; R Petty; H S Jacobs
Journal:  BMJ       Date:  2000-03-25

2.  The male menopause: does it exist?: for: some men need investigation and testosterone treatment

Authors: 
Journal:  West J Med       Date:  2000-08

Review 3.  Andropause: to treat or not to treat?

Authors:  S Basaria; A Dobs
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 4.  Andropause: is the emperor wearing any clothes?

Authors:  S H Tariq; M T Haren; M J Kim; J E Morley
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 5.  Androgens, aging, and Alzheimer's disease.

Authors:  Christian J Pike; Emily R Rosario; Thuy-Vi V Nguyen
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

6.  Relationship between testosterone and erectile dysfunction.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

7.  Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone.

Authors:  J E Morley; F Kaiser; W J Raum; H M Perry; J F Flood; J Jensen; A J Silver; E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 8.  Erectile dysfunction in the elderly male.

Authors:  Mehmet İlker Gökçe; Önder Yaman
Journal:  Turk J Urol       Date:  2017-08-03

9.  Serum total testosterone level and identification of late-onset hypogonadism: a community-based study.

Authors:  Sungmin Kang; Hyun Jun Park; Nam Cheol Park
Journal:  Korean J Urol       Date:  2013-09-10

Review 10.  Anorexia in older persons: epidemiology and optimal treatment.

Authors:  J E Morley
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.